Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Washington National Institute of Nursing Research (NINR) |
---|---|
Information provided by: | University of Washington |
ClinicalTrials.gov Identifier: | NCT00167635 |
The purpose of this study is 1) to determine whether a comprehensive self-management intervention is effective in a sample that includes men and women with irritable bowel syndrome, and 2) to determine whether the comprehensive self-management intervention is as effective when delivered over the telephone as compared to a face-to-face approach.
Condition | Intervention | Phase |
---|---|---|
Irritable Bowel Syndrome |
Behavioral: cognitive-behavioral |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Nursing Management of Irritable Bowel Syndrome: Improving Outcomes |
Enrollment: | 188 |
Study Start Date: | January 2003 |
Study Completion Date: | February 2008 |
Primary Completion Date: | February 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Face-to-Face Individualized Comprehensive Self-Management (CSM-FF) Group. Participants in the individualized CSM-FF group will be scheduled for 9 weekly sessions with the nurse therapist followed by post-intervention follow-up assessment.
|
Behavioral: cognitive-behavioral
Cognitive-behavioral over 9 weeks
|
2: Experimental
Telephone Individualized Comprehensive Self-Management (CSM-TEL) Group. Participants in the individualized CSM-FTF group will initially have 2 face-to-face meetings with the nurse therapist, 6 sessions over the phone and the final session face-to-face at 9 weeks.
|
Behavioral: cognitive-behavioral
Cognitive-behavioral over 9 weeks
|
3: No Intervention
Usual Care Control Group (UC). Following randomization the participants in the control group will receive two short phone calls to maintain contact during the comparable 9-week intervention in the treatment groups.
|
Behavioral: cognitive-behavioral
Cognitive-behavioral over 9 weeks
|
Randomization and Intervention Phase. Upon completing the baseline assessment phase, participants will be randomized to one of 3 treatment groups. A customized computer program will be used to do the randomization in an adaptive manner that ensures the 3 groups remain fairly balanced with respect to possible important predictors of outcomes: age, sex, predominant stool pattern (alternating, constipation-predominant or diarrhea-predominant), and severity of IBS symptoms and psychological symptoms at baseline. When each new participant is randomized, the program will adjust the probabilities of assignment to the three groups so that there is a higher probability of assignment to the group that results in the best balance.
Intervention Groups. Face-to-Face Individualized Comprehensive Self-Management (CSM-FF) Group. Participants in the individualized CSM-FF group will be scheduled for 9 weekly sessions with the nurse therapist followed by post-intervention follow-up assessment.
Telephone Individualized Comprehensive Self-Management (CSM-TEL) Group. Participants in the individualized CSM-TEL group will initially have 2 face-to-face meetings with the nurse therapist, 6 sessions over the phone and the final session face-to-face at 9 weeks.
Usual Care Control Group (UC). Following randomization the participants in the control group will no receive any contacts during the comparable 9-week intervention in the treatment groups.
Follow-up Phase. Participants in all 3 groups will be reassessed at 3-mo, 6-mo, and 12-mo post randomization. At this time the participants will complete questionnaires, a 4 week diary and collect 4 urines.
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Washington | |
University of Washington | |
Seattle, Washington, United States, 98195 | |
Northgate Executive 1 | |
Seattle, Washington, United States, 98125 |
Principal Investigator: | Margaret M Heitkemper | University of Washington |
Responsible Party: | University of Washington ( Margaret Heitkember ) |
Study ID Numbers: | 97-3895-C/E11, 2R01NR04142-5 |
Study First Received: | September 9, 2005 |
Last Updated: | March 25, 2008 |
ClinicalTrials.gov Identifier: | NCT00167635 |
Health Authority: | United States: Institutional Review Board |
Irritable Bowel Syndrome Cognitive-behavioral intervention Psychological distress Quality of life |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Irritable Bowel Syndrome |
Quality of Life Intestinal Diseases Colonic Diseases, Functional |
Pathologic Processes Disease Syndrome |